Objectives: To further characterize PTLS and to aid in clinical diagnosis, parent counseling and patient management.
Methods: Fifteen patients participated in a clinical protocol that included developmental and cognitive profiles, psychiatric assessment, and extensive medical evaluations. Assessment tools included the Mullen Scales of Early Learning or Stanford-Binet Intelligence Scales and Leiter International Performance Scales; Vineland Adaptive Behavior Scales; Behavioral Rating Inventory of Executive Functions; Behavior Assessment System for Children; Aberrant Behavior Checklist, and Short Sensory Profile; the ADI-R and ADOS-G were added after the first seven evaluations. Cytogenetic and molecular analyses were performed on all patients to establish genotype.
Results: The majority of patients (12/15) presented with intellectual disability in the moderate range of impairment and autistic symptoms; unexpectedly, two-thirds (10/15) met strict diagnostic criteria for autism or pervasive developmental disorder, NOS. The most common medical clinical features in these patients included hypotonia, failure to thrive in infancy, obstructive and central sleep apnea, EEG abnormalities, and cardiovascular anomalies.
Conclusions: Although unanticipated, PTLS appears to be very highly associated with autistic spectrum disorders. Continued assessment of patients will allow for clarification of this association and may contribute to our knowledge regarding the etiology of the pervasive developmental disorders.